YiChang HEC ChangJiang Pharmaceutical Yönetim
Yönetim kriter kontrolleri 3/4
YiChang HEC ChangJiang Pharmaceutical CEO'su Juncai Jiang, May2015 tarihinde atandı, in görev süresi 9.5 yıldır. in toplam yıllık tazminatı CN¥ 2.57M olup, şirket hissesi ve opsiyonları dahil olmak üzere 18.7% maaş ve 81.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.008% ine doğrudan sahiptir ve bu hisseler HK$ 609.12K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.3 yıl ve 7.3 yıldır.
Anahtar bilgiler
Juncai Jiang
İcra Kurulu Başkanı
CN¥2.6m
Toplam tazminat
| CEO maaş yüzdesi | 18.7% |
| CEO görev süresi | 9.5yrs |
| CEO sahipliği | 0.008% |
| Yönetim ortalama görev süresi | 7.3yrs |
| Yönetim Kurulu ortalama görev süresi | 7.3yrs |
Son yönetim güncellemeleri
Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥2b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥3m | CN¥482k | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥1b |
| Mar 31 2023 | n/a | n/a | CN¥608m |
| Dec 31 2022 | CN¥1m | CN¥600k | CN¥77m |
| Sep 30 2022 | n/a | n/a | -CN¥18m |
| Jun 30 2022 | n/a | n/a | -CN¥113m |
| Mar 31 2022 | n/a | n/a | -CN¥351m |
| Dec 31 2021 | CN¥1m | CN¥490k | -CN¥588m |
| Sep 30 2021 | n/a | n/a | -CN¥436m |
| Jun 30 2021 | n/a | n/a | -CN¥285m |
| Mar 31 2021 | n/a | n/a | CN¥277m |
| Dec 31 2020 | CN¥756k | CN¥229k | CN¥839m |
| Sep 30 2020 | n/a | n/a | CN¥1b |
| Jun 30 2020 | n/a | n/a | CN¥2b |
| Mar 31 2020 | n/a | n/a | CN¥2b |
| Dec 31 2019 | CN¥393k | CN¥222k | CN¥2b |
| Sep 30 2019 | n/a | n/a | CN¥2b |
| Jun 30 2019 | n/a | n/a | CN¥1b |
| Mar 31 2019 | n/a | n/a | CN¥1b |
| Dec 31 2018 | CN¥365k | CN¥209k | CN¥943m |
| Sep 30 2018 | n/a | n/a | CN¥961m |
| Jun 30 2018 | n/a | n/a | CN¥980m |
| Mar 31 2018 | n/a | n/a | CN¥813m |
| Dec 31 2017 | CN¥324k | CN¥194k | CN¥647m |
Tazminat ve Piyasa: Juncai 'ın toplam tazminatı ($USD 355.29K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 466.36K ).
Tazminat ve Kazançlar: Juncai 'in maaşı son bir yılda %20'den fazla arttı.
CEO
Juncai Jiang (42 yo)
9.5yrs
Görev süresi
CN¥2,572,000
Tazminat
Mr. Juncai Jiang has been General Manager and Executive Director of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. since joining in May 2015. Mr. Jiang served as Deputy Head of the traditional Chinese med...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| GM & Executive Director | 9.5yrs | CN¥2.57m | 0.0076% HK$ 609.1k | |
| Head of the Sales Department | 10.5yrs | CN¥645.00k | Veri yok | |
| Deputy GM & Executive Director | 9.5yrs | CN¥2.71m | 0.0076% HK$ 613.1k | |
| Deputy GM & Executive Director | 9.5yrs | CN¥1.32m | 0.0076% HK$ 609.1k | |
| Executive Director | 1.2yrs | CN¥1.59m | Veri yok | |
| CFO & Head of Finance Department | 5.8yrs | CN¥480.38k | Veri yok | |
| Chief of Quality Division & Employee Representative Supervisor | 7.3yrs | Veri yok | 0.0036% HK$ 292.1k | |
| Joint Company Secretary | 6.1yrs | CN¥370.31k | Veri yok | |
| Joint Company Secretary | 2.8yrs | Veri yok | Veri yok |
7.3yrs
Ortalama Görev Süresi
43yo
Ortalama Yaş
Deneyimli Yönetim: 1558 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.3 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| GM & Executive Director | 9.5yrs | CN¥2.57m | 0.0076% HK$ 609.1k | |
| Deputy GM & Executive Director | 18.8yrs | CN¥2.71m | 0.0076% HK$ 613.1k | |
| Deputy GM & Executive Director | 6.4yrs | CN¥1.32m | 0.0076% HK$ 609.1k | |
| Executive Director | 1.2yrs | CN¥1.59m | Veri yok | |
| Chief of Quality Division & Employee Representative Supervisor | 7.3yrs | Veri yok | 0.0036% HK$ 292.1k | |
| Non-Executive Chairman | 9.5yrs | CN¥32.19m | 0.015% HK$ 1.2m | |
| Independent Non-Executive Director | 9.5yrs | CN¥100.00k | Veri yok | |
| Supervisor | 7.4yrs | Veri yok | 0.0076% HK$ 609.1k | |
| Chairman of the Board of Supervisors | 5.4yrs | Veri yok | Veri yok | |
| Independent Non Executive Director | 4.4yrs | CN¥100.00k | Veri yok | |
| Independent Non-Executive Director | 4.2yrs | CN¥340.00k | 0.00045% HK$ 36.1k |
7.3yrs
Ortalama Görev Süresi
46yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 1558 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.3 yıldır).